Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hepatitis B immune globulin - ADMA Biologics/Nabi Biopharmaceuticals

Next Previous
Drug Profile

Hepatitis B immune globulin - ADMA Biologics/Nabi Biopharmaceuticals

Alternative Names: HBVIg - Biotetst Pharmaceuticals; HBVIg - Nabi Biopharmaceuticals; HEBIG; Hepatitis B immune globulin-human - Biotest Pharmaceuticals; Human hepatitis B immunoglobulin - Biotest Pharmaceuticals; NABI-HB; Nabi-HB

Latest Information Update: 15 Feb 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Developer ADMA Biologics
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hepatitis B
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 15 Feb 2023 9380723; NO UPDATE; Patent information is already covered
  • 05 Mar 2021 Launched for Hepatitis B (Prevention) in South Korea (IM)
  • 03 Mar 2021 ADMA Biologic has patent protection for the compositions and methods of manufacturing, and methods of using the human plasma immunoglobulin for the treatment of immunodeficiency in USA and Europe

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top